Aditi Jain, Abhay Vispute, Amol Dange, Arindam Naskar, Asish Mondal, B Vivekanand, Balram Sharma, Deepak Varade, Dhaiwat Shukla, Girish Bhatia, Harshal Chaudhari, K Ram Babu, Onkar Gavali, Sanket Sorate, Shaishav Bhanushali, Vaibhav Kothari, Vipul Khandelwal, Akhilesh Sharma, Roshan Pawar, Mayur Mayabhate, Vinayaka Shahavi, Aashishsingh Rajput, Mukesh Jaiswal
INTRODUCTION: The aim of the study was to evaluate the efficacy and safety of fixed-dose combination (FDC) of dapagliflozin (10 mg) and linagliptin (5 mg) in comparison to linagliptin 5 mg (Trajenta) in patients with insufficiently controlled type 2 diabetes mellitus (T2DM) on metformin monotherapy. METHODS: The double-blind, randomized, multicentric, parallel-group phase III trial screened 287 adult patients with T2DM (age 18-65 years) from 16 sites across India...
January 2024: Diabetes Therapy: Research, Treatment and Education of Diabetes and related Disorders